Delivery Order SPE2DB20D1109-SPE2DB22FN01K
- Not listed
- This federal contract award, valued at $1,434.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is for the delivery of 4,563,302,837 units of Doxycycline Hyclate 100 mg tablets in 500-count packages, with a completion date of January 12, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop...
- This federal contract award, valued at $1,214.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,557,411,925 units of Doxycycline Hyclate 100 mg tablets, a pharmaceutical product, with a completion date of June 3, 2022. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the...
- This federal contract award, valued at $6,313.06, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,564,545,438 doxycycline hyclate 100 mg tablets in quantities of 1,000 per bottle. The contract is a delivery order with a firm fixed price, and has an ultimate completion date of May 10, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide 4,561,258,619 units of Doxycycline Hyclate 100 mg tablets to the Defense Logistics Agency (DLA). The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,913.86 firm fixed-price delivery order is for the supply of 4,558,302,746 units of Doxycycline Hyclate 100 mg capsules. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,275.79 firm fixed-price contract is for the delivery of 4,558,471,599 Doxycycline Hyclate 100 mg tablets. The contract has a period of performance ending on September 16, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,556,448 units of doxycycline hyclate 100 mg tablets, with a ceiling value of $2,531.18. It is a Firm Fixed Price Delivery Order contract with a period of performance ending on March 4, 2022. The contract was awarded on March 3, 2022 and was not set aside for any specific business type. Amerisourcebergen Drug Corp is a major...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,000 units of Doxycycline Hyclate 100 mg tablets, with a firm fixed price of $1,928.22 and an ultimate completion date of June 27, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with...
- This federal contract award, valued at $2,384.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,232,723 units of Doxycycline Hyclate 100 mg tablets, a common antibiotic medication. The contract is a Firm Fixed Price Delivery Order with a performance period through May 14, 2025. It is not designated as a set-aside contract, indicating open competition....
- This federal contract award is for the delivery of 4,558,215,402 units of Doxycycline Hyclate 100 mg tablets in lots of 500 to the Defense Logistics Agency (DLA). The $1,131.63 Firm Fixed Price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The award is not designated as a set-aside contract....
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB22FN01KDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,303.57 firm fixed-price contract is for the delivery of 4,555,299,540 units of doxycycline hyclate 100 mg tablets. The contract is not designated as a set-aside and was awarded on an unrestricted, full and open competitive basis. It is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. Cencora, Inc. also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These contracts demonstrate Amerisourcebergen's and Cencora's roles as key suppliers of essential pharmaceutical and medical products to various federal government agencies, particularly the Department of Defense and Department of Veterans Affairs, to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 11/3/21 |